Search Results
494 items found for "Bcl-2"
- 📰 GPCR Weekly News, April 17 to 23, 2023
Below is your Classified GPCR News at a glance for April 17 to 23, 2023. (May 18 - 21, 2023). (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs NEW Postdoctoral
- 📰 GPCR Weekly News, April 10 to 16, 2023
(April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics (May 18 - 21, 2023). (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs NEW Director -
- Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...
October 2022 Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity In rodents, intrathecal injection of its ligand, 7α,25-dihydroxycholesterol (7α,25-OHC), causes time-dependent Here, we show that 7α,25-OHC-induced behavioral hypersensitivity is Gα i dependent, but not β-arrestin 2-dependent. In support, we found that the development of 7α,25-OHC/GPR183-induced mechano-allodynia was associated
- 📰 GPCR Weekly News, January 23 to 29, 2023
to the 29th, 2023. , (February 21 - 23, 2023), Boston. (April 20 - 21, 2023) SLAS Europe 2023 Conference and Exhibition. (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (July 2 - 7, 2023).
- 📰 GPCR Weekly News, March 13 to 19, 2023
(March 23, 2023) NEW 5th ERNEST GPCR ECI zoominar. (April 20 - 21, 2023) NEW Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs Postdoctoral positions
- Adhesion GPCR Consortium Newsletter - May 2024
Announcements Please save the date for the 2024 aGPCR workshop hosted by Antony Boucard! This exciting conference will take place from October 23-25th. We'll see you in Mexico City! When in Mexico City from 23-25 October, here is my bucket list of the 3 things that people should absolutely
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
November 2021 Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research Grants at the World Diabetes Day Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of the 2022 are investigating new ways to tackle the disease-inducing chronic inflammation that is linked to type 2
- 📰 GPCR Weekly News, April 29 to May 5, 2024
Hello readers! We got a little busy with all the major events at Dr.GPCR, so our weekly news looks slightly different. We will be back next week with our regular weekly GPCR news digest. In the meantime, you can always check the Classified GPCR News from the last weeks. Today, we celebrate a huge milestone by releasing Episode #150 of the Dr. GPCR Podcast. Join us in this wonderful episode to meet the team of volunteers behind the work you see. The story behind how Dr.GPCR came to be, the people behind the process, the great anecdotes, and what’s coming next. We also have some important announcements in today’s episode, so join us in this celebration and be the first to know about all the changes coming to Dr. GPCR. Today is also the first session of our hands-on workshop with Dr. Sam Hoare. If you aren't joining us this time, stay tuned for more Dr. GPCR University content coming soon.
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
June 2022 Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2022 "06/13/22 - Substantial Reductions in Key Hormones and Hormone Precursors Adolescents with Classic CAH - Two Phase 3 Global Registrational Studies Currently Underway in Pediatric (2– (Nasdaq: NBIX) today announced that it will present new Phase 2 data on the use of crinecerfont in adolescent patients with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD)
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
October 2022 "Heterotrimeric G proteins couple activated G protein-coupled receptors (GPCR) to intracellular YM-254890 (YM) can inhibit signaling by both GPCR-activated wild type αq and GPCR-independent αqQ209L
- G protein-coupled receptor 21 in macrophages: An in vitro study
August 2022 "GPR21 is an orphan and constitutively active receptor belonging to the superfamily of G-Protein
- 📅 Dr. GPCR Summit 2022 is less than a month away!
GPCR Summit 2022 is less than a month away!
- Don't miss the chance to be part of the Dr. GPCR Summit 2022!
GPCR Summit 2022 held between Oct. 10 - 16, it's FREE! Join the #GPCR movement by signing up now!
- Dr. GPCR Summit 2022 is coming!
GPCR Summit 2022 held between October 10th and 16th. Dr.
- Dr. GPCR Summit 2022 is coming!
➡️ https://www.ecosystem.drgpcr.com/dr-gpcr-summit-2022 #gpcr #drgpcr
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
March 2022 " Geneva, Switzerland, March 7, 2022 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage allosteric modulation-based drug discovery and development, announced today that it will issue its full-year 2021 financial results on Thursday, March 10, 2022.
- 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry. October 5-7, 2022, Verona, Italy
August 2022 "GPCRs in Medicinal Chemistry Event 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry Dates Wednesday-Friday, 5th-7th October 2022 Place Evotec Campus Levi-Montalcini, Verona, Italy Downloads
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
August 2022 "August 12, 2022.- Jan Steyaert , scientific director of the VIB-VUB Center for Structural Biotechnologie , at the Vrije Universiteit Brusle, Brussels, Belgium, has been named the winner of Brandeis’ 24th Jan Steyaert will be presented with the Gabbay Award at Brandeis University on October 27 when he will
- Trevena Reports Second Quarter 2022 Results and Provides Business Update
August 2022 "CHESTERBROOK, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Trevena , Inc. system (CNS) disorders, today reported its financial results for the second quarter ended June 30, 2022
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
August 2022 RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022.
- Discovery On Target, October 17-20, 2022, Boston, USA
August 2022 "Join Us in Boston for Discovery On Target 2022!
- 4GPCRnet, September 26-29, 2022. Leipzig, Germany
August 2022 "WELCOME 4GPCRnet meeting bringing together four of the biggest GPCR networks in Europe for SFB1423 and FOR2372) have joined forces to organize an international meeting, which will take place from 26th -29th September 2022 in the beautiful city of Leipzig in Germany.
- 2nd IRN i-GPCRnet, September 30 to October 1st, 2022. University of Wurzburg, Germany
August 2022 "We are happy to announce you our 2nd IRN i-GPCRnet meeting that will be held at the University
- AcroScreen co-founder Margaux Duchamp has been selected as a 30 under 30 Europe Forbes ranking 2022
May 2022 "We are thrilled to announce that our co-founder Margaux Duchamp has been selected as a 30 under 30 Europe Forbes ranking 2022 for science and healthcare.
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
October 2022 "Psychedelics, also known as classical hallucinogens, affect processes related to perception includes lysergic acid diethylamide (LSD), psilocybin, mescaline and the substituted amphetamine 1-(2,5 -dimethoxy-4-iodophenyl)-2-aminopropane (DOI), is receiving renewed attention for their potential therapeutic
- AELIS PHARMA launches their IPO for €25 million
February 2022 "We are proud to announce the success of our IPO! The €25 million fundraising gives us the means to achieve our ambitions: to become a leading player in
- Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water ...
Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water flea Here, we identified a total 216 full-length GPCR genes in the marine water flea Diaphanosoma celebensis
- Join Dr. GPCR Summit 2022 in 3 simple steps!
🌟The Dr. GPCR event of the year is the 3rd edition of the Summit. Come join us from October 10 to 16 to hear about exciting #GPCR research from amazing speakers. Become a Dr. GPCR Ecosystem site member to attend the Summit, it’s free! ➡️ https://bit.ly/3SUkB8D #gpcr #drgpcr